stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Design Therapeutics, Inc. | StockGist | StockGist
Companies
DSGN
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
DSGN
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Design Therapeutics, Inc.
Filed Feb 17, 2026
Accepted Feb 16, 2026, 7:00 PM ET
DSGN
CIK 0001807120
View on SEC.gov
Company Profile
0000902664-26-001131
Beneficial Ownership Report
Passive Investment
Reporting Person
Design Therapeutics, Inc.
Person Type
PN
CUSIP: 25056L103
Amendment History
2 filings
SCHEDULE 13G
Original
Aug 28, 2025
0000902664-25-003881
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Feb 17, 2026
0000902664-26-001131